Wu et al. [28] used immunohistochemical techniques to analyze 301 NSCLC tissue samples and found no detectable ERα expression, whereas ERβ was positively expressed in 45.8% of cases. The gene discussed is ESR2; the disease is non-small cell lung carcinoma.